Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Tolerance to benzodiazepine hypnotics overcome with melatonin

June 6, 1997

DynaGen licenses smoking cessation technology

June 6, 1997

FDA clears Glaxo Wellcome's aid to smoking cessation

May 16, 1997

ImmuLogic receives funds from NIH to develop cocaine vaccine

May 12, 1997

Nicotine inhaler cleared by FDA

May 7, 1997

Alza and SmithKline Beecham sign new agreement for Nicoderm

April 22, 1997

Ibogamine congeners for addiction

April 15, 1997

Allelix and Pharm-Eco create partnership

April 10, 1997

PDL and Teijin agreement for MAb to E. coli toxin

April 9, 1997

Genes involved in marijuana abuse

April 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...